The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017
The data on antimicrobial resistance in zoonotic and indicator bacteria in 2017, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food were addressed, and temporal trends assessed.
OECD highlights the progress made in laboratory systems in the EU/EEA since the implementation of EULabCap
The OECD report ‘Health at a Glance: Europe 2018’ summarises the EULabCap indicator results in the chapter on public health laboratory capacity to control infectious disease threats.
Call for scientific collaboration to support genomic-based surveillance of Neisseria gonorrhoeae-antimicrobial resistance at EU-level
ECDC is looking to establish a scientific collaboration with an organisation which can perform whole genome sequencing (WGS) of Neisseria gonorrhoeae, carry out related data analyses, share results of the analyses with ECDC and the participants of the European Gonococcal Antimicrobial Surveillance Programme as well as visualise the results.
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017
This report provides an analysis of the external quality assessment (EQA) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2017.
Rapid risk assessment: Multidrug-resistant Staphylococcus epidermidis
This rapid risk assessment addresses the public health risk associated with a previously unrecognised international spread of near pandrug-resistant strains of S. epidermidis as a cause of infection in several countries including EU Member States.
Drug-resistance of gonorrhoea in the EU: persistent but stable
Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).
Healthcare-associated pneumonia in acute care hospitals in European union/European economic area countries: An analysis of data from a point prevalence survey, 2011 to 2012
Walter, J., Haller, S., Quinten, C., Kärki, T., Zacher, B., Eckmanns, T., Abu Sin, M., Plachouras, D., Kinross, P., Suetens, C., Strauss, R., Mertens, K., Dobreva, E., Budimir, A., Hadjiloucas, A., Prattingerová, J., Kristensen, B., Monnet, D.L., Märtin, P., Lyytikäinen, O., Giard, M., Piening, B., Kritsotakis, E.I., Kurcz, A., Gudlaugsson, Ó., Burns, K., Moro, M.L., Dumpis, U., Ašembergienė, J., Heisbourg, E., Xuereb, D., Hopmans, T., Sorknes, N.K., Deptuła, A., Paiva, J.-A., Serban, R., Litvová, S., Kolman, J., Lozano, J., Struwe, J., Hopkins, S., Doherty, L., Reilly, J.S., Harrison, W.
Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey
Harris, S.R., Cole, M.J., Spiteri, G., Sánchez-Busó, L., Golparian, D., Jacobsson, S., Goater, R., Abudahab, K., Yeats, C.A., Bercot, B., Borrego, M.J., Crowley, B., Stefanelli, P., Tripodo, F., Abad, R., Aanensen, D.M., Unemo, M., Azevedo, J., Balla, E., Barbara, C., Bergheim, T., Borrego, M.J., Bremer, V., Buder, S., Maikanti-Charalambous, P., Chisholm, S., Cowan, S., Crowley, B., Crucitti, T., Diez, M., Dudás, M., Eastick, K., Goubard, A., Haller, M., Hauksdóttir, G.S., Hoffmann, S., Hughes, G., Igoe, D., Jeverica, S., Klavs, I., Kløvstad, H., Kohl, P., Konte, V., Linde, I., Mavcutko, V., Melillo, J.M., Pakarna, G., Pavlik, P., Pieridou, D., La Ruche, G., Sigmundsdóttir, G., Soteriou, S., Stary, A., Stefanelli, P., Suligoi, B., Truska, P., Tzelepi, E., Unemo, M., Van Benthem, B., Van Dam, A., Vazquez, J., Velicko, I., Verbrugge, R.
Rapid risk assessment: Candida auris in healthcare settings – Europe
This rapid risk assessment update appraises the risk for spread of C. auris in hospitals in the European Union and European Economic Area (EU/EEA) countries
Emerging spread of new fungal species poses risk for healthcare settings in the EU/EEA
The rise in Europe of Candida auris infections, a difficult-to-control fungus, is of concern. The fungus spreads easily in healthcare settings, can cause invasive infections, and is also associated with resistance to multiple classes of anti-fungal medication.